Evidence map›Paper›PMID 40822234›Full record

ArticleJournal of the American Statistical Association2025

Immune Profiling among Colorectal Cancer Subtypes using Dependent Mixture Models.

Yunshan Duan, Shuai Guo, Wenyi Wang, Peter Müller

Abstract read
In one paragraph

Article in Journal of the American Statistical Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yunshan DuanDepartment of Statistics, University of Texas at Austin.
Shuai GuoDepartment of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center.
Wenyi WangDepartment of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center.
Peter MüllerDepartment of Statistics, University of Texas at Austin.

Funding

Statistical methods for genomic analysis of heterogeneous tumorsR01CA268380 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Wenyi Wang · 2022 to 2026
$2.4M
NCI NIH HHS R01 CA268380
6 · The paper itself

Abstract

Comparison of transcriptomic data across different conditions is of interest in many biomedical studies. In this paper, we consider comparative immune cell profiling for early-onset (EO) versus late-onset (LO) colorectal cancer (CRC). EOCRC, diagnosed between ages 18-45, is a rising public health concern that needs to be urgently addressed. However, its etiology remains poorly understood. We work towards filling this gap by identifying homogeneous T cell sub-populations that show significantly distinct characteristics across the two tumor types, and identifying others that are shared between EOCRC and LOCRC. We develop dependent finite mixture models where immune subtypes enriched under a specific condition are characterized by terms in the mixture model with common atoms but distinct weights across conditions, whereas common subtypes are characterized by sharing both atoms and relative weights. The proposed model facilitates the desired comparison across conditions by introducing highly structured multi-layer Dirichlet priors. We illustrate inference with simulation studies and data examples. Results identify EO- and LO-enriched T cells subtypes whose biomarkers are found to be linked to mechanisms of tumor progression, and potentially motivate insights into treatment of CRC. Code implementing the proposed method is available at: https://github.com/YunshanDYS/SASCcode.

Indexed as

Common atoms modelComparison across conditionsEarly-onset colorectal cancerFinite mixture model

Identifiers

PMID40822234
PMCPMC12356147

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.